Maria Baggstrom

Advancing the state of knowledge in medical oncology, Maria Baggstrom serves as a Professor of Medicine at Washington University School of Medicine. With a specialization in Medical Oncology, she is deeply involved in the development and execution of phase I and II clinical trials, particularly for lung cancer patients. Her affiliation with the Institute of Clinical and Translational Sciences and the Siteman Cancer Center underscores her commitment to pioneering research in cancer treatment. Maria's research interests are centered around clinical trials, where she focuses on integrating personalized medicine and targeted therapies. Her work aims to enhance the efficacy of cancer treatments by tailoring them to individual patient profiles, thereby improving outcomes and minimizing side effects. This approach not only advances the field of oncology but also sets a new standard for patient care. In addition to her research, Maria is dedicated to advancing medical education. She actively participates in training the next generation of oncologists, emphasizing the importance of clinical trial methodology and the integration of innovative therapies in treatment plans. Her educational efforts ensure that emerging medical professionals are well-equipped to contribute to the evolving landscape of cancer treatment. Maria's contributions to the field are not limited to her research and teaching. She is an advocate for collaboration across disciplines, recognizing that the complex nature of cancer requires a multifaceted approach. Her work often involves partnerships with other researchers and institutions, fostering an environment of shared knowledge and collective progress. Through her dedication to clinical trials and personalized medicine, Maria Baggstrom continues to make significant strides in the fight against cancer. Her efforts not only benefit her patients but also contribute to the broader medical community's understanding of how to effectively combat this challenging disease.